Rohto Pharmaceutical Co (FRA:UC1) E10: €0.51 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UC1 Rohto Pharmaceutical Co Ltd FRA:UC1
73 GF Score
Price €12.90
GF Value €18.58
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Rohto Pharmaceutical Co E10?

Rohto Pharmaceutical Co FRA:UC1 -1.53% 73 E10 is €0.51 as of Mar. 2026. GuruFocus rates FRA:UC1 with a GF Score™ of 73/100 and a GF Value™ of €18.58 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rohto Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.132. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.51 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Rohto Pharmaceutical Co's average E10 Growth Rate was 13.20% per year. During the past 3 years, the average E10 Growth Rate was 15.80% per year. During the past 5 years, the average E10 Growth Rate was 16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Rohto Pharmaceutical Co was 17.50% per year. The lowest was 6.70% per year. And the median was 14.55% per year.

As of today (2026-07-22), Rohto Pharmaceutical Co's current stock price is €12.90. Rohto Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was €0.51. Rohto Pharmaceutical Co's Shiller PE Ratio of today is 25.29.

During the past 13 years, the highest Shiller PE Ratio of Rohto Pharmaceutical Co was 62.06. The lowest was 22.94. And the median was 37.75.


Rohto Pharmaceutical Co  (FRA:UC1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Rohto Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=12.90/0.51
=25.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Rohto Pharmaceutical Co was 62.06. The lowest was 22.94. And the median was 37.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Rohto Pharmaceutical Co E10 Related Terms


Rohto Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Rohto Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co E10 Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.51

Rohto Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.52 0.51 0.51 0.51

FRA:UC1 vs PG, CL, KVUE: E10 Comparison

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co Shiller PE Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Shiller PE Ratio falls into.


FRA:UC1
73GF Score
Rohto Pharmaceutical Co Ltd FRA:UC1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rohto Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rohto Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.132/112.7000*112.7000
=0.132

Current CPI (Mar. 2026) = 112.7000.

Rohto Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.051 98.100 0.059
201609 0.108 98.000 0.124
201612 0.151 98.400 0.173
201703 0.058 98.100 0.067
201706 0.080 98.500 0.092
201709 0.112 98.800 0.128
201712 0.146 99.400 0.166
201803 -0.027 99.200 -0.031
201806 0.117 99.200 0.133
201809 0.130 99.900 0.147
201812 0.122 99.700 0.138
201903 -0.037 99.700 -0.042
201906 0.079 99.800 0.089
201909 0.188 100.100 0.212
201912 0.190 100.500 0.213
202003 0.105 100.300 0.118
202006 0.063 99.900 0.071
202009 0.142 99.900 0.160
202012 0.170 99.300 0.193
202103 0.204 99.900 0.230
202106 0.156 99.500 0.177
202109 0.212 100.100 0.239
202112 0.207 100.100 0.233
202203 0.134 101.100 0.149
202206 0.216 101.800 0.239
202209 0.191 103.100 0.209
202212 0.258 104.100 0.279
202303 0.145 104.400 0.157
202306 0.259 105.200 0.277
202309 0.208 106.200 0.221
202312 0.266 106.800 0.281
202403 0.128 107.200 0.135
202406 0.218 108.200 0.227
202409 0.122 108.900 0.126
202412 0.323 110.700 0.329
202503 0.163 111.100 0.165
202506 0.313 111.700 0.316
202509 0.140 112.000 0.141
202512 0.245 113.000 0.244
202603 0.132 112.700 0.132

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.51 mean?
Rohto Pharmaceutical Co (FRA:UC1) has a E10 of €0.51 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Rohto Pharmaceutical Co and its competitors.
Is Rohto Pharmaceutical Co's E10 too high?
Rohto Pharmaceutical Co's current E10 is €0.51. Overall, Rohto Pharmaceutical Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's E10 compare to PG and CL?
Rohto Pharmaceutical Co's E10 of €0.51 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Consumer Packaged Goods company?
A good E10 depends on the Consumer Packaged Goods industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Rohto Pharmaceutical Co and its competitors. Rohto Pharmaceutical Co's current E10 is €0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co (FRA:UC1) is currently considered Significantly Undervalued. The stock's GF Value™ is €18.58, compared to a current price of €12.90 — trading 30.6% below its estimated fair value. The current E10 is €0.51. Rohto Pharmaceutical Co's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Rohto Pharmaceutical Co (FRA:UC1), the current E10 is €0.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rohto Pharmaceutical Co (FRA:UC1) Overvalued in 2026?

Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued. The current stock price of €12.90 is trading 30.6% below its estimated GF Value™ of €18.58. GuruFocus considers Rohto Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for FRA:UC1:

  • E10: €0.51
  • GF Value™: €18.58 vs. price of €12.90 (30.6% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the FRA:UC1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rohto Pharmaceutical Co Business Description

Other Exchanges RPHCF:USA4527:Japan
Address 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
73GF Score

Get the complete analysis for FRA:UC1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.90
Price
€18.58
GF Value